The Patent Finder

Arrien Pharmaceuticals LLC

Also on record
Records under this name other than the patents Arrien Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 2 of 2 · Back to Arrien Pharmaceuticals LLC

PatentTitleStatus Expires Confidence
US 9,359,315Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,890,153Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
Lapsed on the fee record
Ended Feb 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 13, 2026From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited